Ann: Dronabinol Supply Agreement/Sleep Apnoea Trial Update, page-40

The way I look at it, we're not a mining company that's digging lots of holes and trying to discover something of value. To some extent we're following the same path that a few of the other MedCan companies have already travelled down although we are a lot more multi dimensional as we have the dental side as well as the MedCan side; the trials if/when successful gives us the IP to all of those remedies to counter ailments that are widespread and for which there are no adequate solutions for; this could be massive.

Relative to the other MedCan companies that are averaging around the $150M - $200M MC, we are still sitting at a measly $25M - we have a lot of catching up to do and this is what gives me comfort in my investment. There is absolutely NO REASON why any of those companies should have a significantly higher MC and we will catch them, no doubt about it in my mind.

This is an exciting play and anyone that got in early or gets in very soon will be handsomely rewarded IMO....

As always, DYOR and GLTAH....